A Brief Intervention to Improve Adherence in Teens With Inflammatory Bowel Disease (PHONE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01237847|
Recruitment Status : Unknown
Verified November 2010 by Rosalind Franklin University of Medicine and Science.
Recruitment status was: Active, not recruiting
First Posted : November 10, 2010
Last Update Posted : November 10, 2010
|Condition or disease||Intervention/treatment||Phase|
|Inflammatory Bowel Disease||Behavioral: 2 Family-based problem solving phone sessions Behavioral: 4 Family-based problem solving phone intervention sessions Behavioral: Wait list comparison group||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||90 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||A Brief Intervention to Improve Adherence in Teens With Inflammatory Bowel Disease|
|Study Start Date :||July 2010|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||July 2013|
Behavioral: Wait list comparison group
Wait list comparison group to receive intervention at later point.
|Experimental: 2 phone sessions||
Behavioral: 2 Family-based problem solving phone sessions
2 family-based problem solving phone sessions to address and ameliorate barriers to adherence.
|Experimental: 4 phone sessions||
Behavioral: 4 Family-based problem solving phone intervention sessions
4 family-based problem solving phone sessions to address and ameliorate barriers to adherence.
- Adherence [ Time Frame: beginning at baseline - week 20 ]participants will use MEMS bottles to capture adherence data from participant week 0 - participant week 20. Additionally, adherence interviews and pill counts will be conducted at participant week 0, 12, and 20.
- Quality of Life [ Time Frame: at baseline, week 12, and week 20 ]
- Adherence barriers [ Time Frame: at baseline, week 12, and week 20 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01237847
|United States, Wisconsin|
|Children's Hospital of Wisconsin|
|Milwaukee, Wisconsin, United States, 53213|
|Principal Investigator:||Rachel Neff Greenley, PhD||Rosalind Franklin University of Medicine and Science|